Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Genscript Biotech Corp is planning to spin-off and list subsidiary Legend Biotech Corp in a potential $100m Nasdaq IPO. The firm submitted listing documents to the US regulator on Wednesday. -
Central American sovereign Belize, which last restructured its international debt in 2017, is likely to seek to delay a $13m coupon payment due in August on its only external bond, believes Moody’s.
-
The International Monetary Fund is likely to approve a request from Chilean authorities for a two year flexible credit line (FCL) that the country’s central bank says is being sought “to reinforce the external position in a high risk external scenario”.
-
Airbus subsidiary Skytra has picked Nasdaq Clearing as the clearing house for its derivatives trading platform, which will offer airlines the ability to hedge revenue risk. With the industry in crisis, Skytra’s COO says there is more interest in the offering than ever.
-
Woolworths reopened the Australian dollar corporate market with a A$1bn ($645m) dual tranche trade on Wednesday, the first from a corporate since the end of February.
-
US taxi company Lyft has issued a new $650m convertible bond to raise capital to see itself through the Covid-19 crisis, joining the horde of US companies that have turned US equity-linked into one of the hottest corners of the capital markets during the pandemic.
